Masahiro Aoki

6.2k total citations
71 papers, 4.9k citations indexed

About

Masahiro Aoki is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Masahiro Aoki has authored 71 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Masahiro Aoki's work include PI3K/AKT/mTOR signaling in cancer (15 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Wnt/β-catenin signaling in development and cancer (7 papers). Masahiro Aoki is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (15 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Wnt/β-catenin signaling in development and cancer (7 papers). Masahiro Aoki collaborates with scholars based in Japan, United States and Germany. Masahiro Aoki's co-authors include Peter K. Vogt, Teruaki Fujishita, Makoto M. Taketo, Bing‐Hua Jiang, Jenny Z. Zheng, Philip N. Tsichlis, Alfonso Bellacosa, Hao Jiang, Masanobu Oshima and Takanori Kitamura and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Masahiro Aoki

71 papers receiving 4.8k citations

Peers

Countries citing papers authored by Masahiro Aoki

Since Specialization

Citations

This map shows the geographic impact of Masahiro Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Aoki more than expected).

Fields of papers citing papers by Masahiro Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Aoki. The network helps show where Masahiro Aoki may publish in the future.

Co-authorship network of co-authors of Masahiro Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Aoki. A scholar is included among the top collaborators of Masahiro Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Aoki. Masahiro Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TGF‐β signaling promotes desmoid tumor formation via CSRP2 upregulation 2023 ·Cancer Science ·Yu Li, Teruaki Fujishita, Emi Mishiro‐Sato, Yasushi Kojima, Yanqing Niu, Makoto M. Taketo, (unknown), Tomohisa Sakai, Atsushi Enomoto, Yoshihiro Nishida, Masahiro Aoki	3
2	The cAMP/PKA/CREB and TGFβ/SMAD4 Pathways Regulate Stemness and Metastatic Potential in Colorectal Cancer Cells 2022 ·Cancer Research ·Teruaki Fujishita, Yasushi Kojima, Rie Kajino‐Sakamoto, Emi Mishiro‐Sato, Yasuhiro Shimizu, Waki Hosoda, Rui Yamaguchi, Makoto M. Taketo, Masahiro Aoki	36
3	MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L‐like during epithelial‐mesenchymal transition 2021 ·Cancer Science ·Keiichiro Sakuma, Eiichi Sasaki, Waki Hosoda, Koji Komori, Yasuhiro Shimizu, Yasushi Yatabe, Masahiro Aoki	4
4	Acquired JHDM1D–BRAF Fusion Confers Resistance to FGFR Inhibition in FGFR2 -Amplified Gastric Cancer 2018 ·Molecular Cancer Therapeutics ·Hitoshi Sase, Yoshito Nakanishi, Satoshi Aida, (unknown), (unknown), Toshihiko Fujii, Kiyoaki Sakata, Toshiyuki Mio, Masahiro Aoki, Nobuya Ishii	17
5	TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation 2018 ·Oncogene ·(unknown), Tatsuhiro Sato, (unknown), Teruaki Fujishita, Emi Mishiro‐Sato, (unknown), Masahiro Aoki, Yoshinori Hasegawa, Yoshitaka Sekido	21
6	Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma 2016 ·Cancer Research ·Naoki Hijiya, Yoshiyuki Tsukamoto, Chisato Nakada, Lam Tung Nguyen, (unknown), Keiko Matsuura, Kohei Shibata, Masafumi Inomata, Tomohisa Uchida, Akinori Tokunaga, (unknown), Kuniaki Shirao, Yasunari Yamada, Hiromu Mori, Ichiro Takeuchi, Masao Seto, Masahiro Aoki, Mutsuhiro Takekawa, Masatsugu Moriyama	45
7	Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1 2015 ·Molecular Cancer Therapeutics ·Yoshito Nakanishi, (unknown), Toshiyuki Tsukaguchi, Toshihiko Fujii, Yasuko Satoh, Nobuya Ishii, Masahiro Aoki	51
8	ERK Signal Suppression and Sensitivity to CH5183284/Debio 1347, a Selective FGFR Inhibitor 2015 ·Molecular Cancer Therapeutics ·Yoshito Nakanishi, Hideaki Mizuno, Hitoshi Sase, Toshihiko Fujii, Kiyoaki Sakata, (unknown), Yuko Aoki, Masahiro Aoki, Nobuya Ishii	24
9	Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in Apc^Δ716 mice involves stromal COX‐2 2015 ·Cancer Science ·Teruaki Fujishita, Rie Kajino‐Sakamoto, Yasushi Kojima, Makoto M. Taketo, Masahiro Aoki	6
10	Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression 2014 ·Molecular Cancer Therapeutics ·Yuji Sano, Eri Hashimoto, Noriaki Nakatani, (unknown), Yasuko Satoh, Kiyoaki Sakata, Toshihiko Fujii, Kaori Fujimoto-Ouchi, Masamichi Sugimoto, Shigehisa Nagahashi, Masahiro Aoki, (unknown), Eiichi Sasaki, Yasushi Yatabe	22
11	Sialic acid cyclization of human Th homing receptor glycan associated with recurrent exacerbations of atopic dermatitis 2012 ·Journal of Dermatological Science ·Keiichiro Sakuma, Takuya Furuhashi, Sachiko Kondo, (unknown), Katsuyuki Ohmori, Hidemi Ito, Masahiro Aoki, Akimichi Morita, Reiji Kannagi	1
12	Suppression of Colonic Polyposis by Homeoprotein CDX2 through its Nontranscriptional Function that Stabilizes p27Kip1 2011 ·Cancer Research ·Koji Aoki, Fumihiko Kakizaki, Hiromi Sakashita, Toshiaki Manabe, Masahiro Aoki, Makoto M. Taketo	30
13	JNK Signaling Promotes Intestinal Tumorigenesis Through Activation of mTOR Complex 1 in ApcΔ716 Mice 2011 ·Gastroenterology ·Teruaki Fujishita, Masahiro Aoki, Makoto M. Taketo	33
14	Reduced Level of Smoothened Suppresses Intestinal Tumorigenesis by Down-Regulation of Wnt Signaling 2009 ·Gastroenterology ·(unknown), Akihiro Matsunaga, Takanori Kitamura, Koji Aoki, Masahiro Aoki, Makoto M. Taketo	51
15	Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc ^Δ716 mice 2008 ·Proceedings of the National Academy of Sciences ·Teruaki Fujishita, Koji Aoki, Heidi A. Lane, Masahiro Aoki, Makoto M. Taketo	135
16	Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells 2008 ·The EMBO Journal ·K. Oguma, Hiroko Oshima, Masahiro Aoki, Ryusei Uchio, Kazuhito Naka, Satoshi Nakamura, Atsushi Hirao, Hideyuki Saya, Makoto M. Taketo, Masanobu Oshima	234
17	The Catalytic Subunit of Phosphoinositide 3-Kinase: Requirements for Oncogenicity 2000 ·Journal of Biological Chemistry ·Masahiro Aoki, Christian Schetter, Martin Himly, (unknown), Hwai Wen Chang, Peter K. Vogt	77
18	LAPAROSCOPIC ADRENALECTOMY FOR CUSING'S SYNDROME 1996 ·The Japanese Journal of Urology ·(unknown), Hiroshi Shinbo, Masahiro Aoki, Akiko Ishikawa, Shinji Kageyama, Soichi Mugiya, Yoshihisa Ohtawara, Kenji Suzuki, (unknown)	1
19	Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody 1993 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), Masahiro Aoki, Akira Moriguchi, (unknown), Masahiko Miyata, Hikaru Matsuda	7
20	Naturally occurring cytotoxic T lymphocyte precursors with specificity for an Ig idiotype. 1988 ·The Journal of Immunology ·(unknown), Kyohei Yamada, Noriko Ohno, Masahiro Aoki, (unknown), Alfred Nisonoff, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact